OverviewSuggest Edit

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. ... Show more
TypePublic
Founded1923
HQBagsvaerd, DK
Websitenovonordisk.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Dec 2017)42,076(+2%)
Job Openings281
Share Price (Feb 2019)$49.1

Key People/Management at Novo Nordisk

Lars Rebien Sørensen

Lars Rebien Sørensen

President & Chief Executive Officer
Jesper Brandgaard

Jesper Brandgaard

EVP and Chief Financial Officer
Maziar Mike Doustdar

Maziar Mike Doustdar

EVP of International Operations
Lars Fruergaard Jørgensen

Lars Fruergaard Jørgensen

EVP Corporate Developemnt
Show more

Novo Nordisk Office Locations

Novo Nordisk has offices in Bagsvaerd, San Francisco, Brooklyn, and in 138 other locations
Bagsvaerd, DK (HQ)
Novo Nordisk A/S Novo Allé
Mississauga, CA
300-2680 Skymark Avenue, Floor 3
Beijing, CN
18F, East Tower, World Financial Center, No. 1 East 3rd Ring Middle Road, Chaoyang District
Mainz, DE
Brucknerstrasse 1
Bangalore, IN
Plot No.32, 47-50, EPIP Area, Whitefield
Tokyo, JP
Meiji Yasuda Seimei Bldg. 2-1-1, Marunouchi, Chiyoda-ku
Show all (142)
Report incorrect company information

Novo Nordisk Financials and Metrics

Novo Nordisk Revenue

Market capitalization (13-Feb-2019)

117.3b

Closing stock price (13-Feb-2019)

49.1
Novo Nordisk's current market capitalization is $117.3 b.
Show all financial metrics

Novo Nordisk Operating Metrics

FY, 2015FY, 2016

Patients Reached

26.80 m

Phase III Trials Products

6 3

Projects in R&D Pipeline

19 17
Show all operating metrics

Novo Nordisk Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
ZiyloAugust 20, 2018$800 m
Report incorrect company information

Novo Nordisk Online and Social Media Presence

Embed Graph
Report incorrect company information

Novo Nordisk News and Updates

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2018. The reports are available at the SEC's we…

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019

Bagsværd, Denmark, 4 February 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

Bleeding Disorders Treatment Market to Witness Huge Growth by 2025 | Leading Key Players- Baxalta, Bayer Pharmaceuticals, Novo Nordisk A/S

Stay up-to-date with Bleeding Disorders Treatment Market offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

Glucagon Market Analysis by Demand, Trend, Market Segment & Forecast to 2025 | Novo Nordisk, Eli Lilly, Fresenius Kabi

HTF MI recently Announced Global Glucagon study with 100+ market data Tables and Figures spread through Pages and easy to understand detailed TOC on "Glucagon. Global Glucagon research allows you to get different methods for maximizing your profit. Posted via Industry Today. Follow us on Twitter @In…

The Ultimate Guide on Specialty Pharmaceutical Market which provides primary trends and market strategies of key players such as Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson

The business and financial overview of various companies have been analyzed in this report Posted via Industry Today. Follow us on Twitter @IndustryToday

women’s health market Growth by Application, Technology Service, Trends, and Forecast to 2025 | Bayer Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Novo Nordisk, Allergan

The Global women’s health Market Report is a valuable source of insightful data for business strategists. It provides the market overview with growth analysis and historical & futuristic cost, revenue, demand and supply data. To boost the performance of the current strategy it gives more focus …
Show more
Report incorrect company information

Novo Nordisk Company Life and Culture

Report incorrect company information

Novo Nordisk Frequently Asked Questions

  • When was Novo Nordisk founded?

    Novo Nordisk was founded in 1923.

  • Who are Novo Nordisk key executives?

    Novo Nordisk's key executives are Lars Rebien Sørensen, Jesper Brandgaard and Maziar Mike Doustdar.

  • How many employees does Novo Nordisk have?

    Novo Nordisk has 42,076 employees.

  • Who are Novo Nordisk competitors?

    Competitors of Novo Nordisk include Gilead Sciences, Amgen and Abbott.

  • Where is Novo Nordisk headquarters?

    Novo Nordisk headquarters is located at Novo Nordisk A/S Novo Allé, Bagsvaerd.

  • Where are Novo Nordisk offices?

    Novo Nordisk has offices in Bagsvaerd, San Francisco, Brooklyn, and in 138 other locations.

  • How many offices does Novo Nordisk have?

    Novo Nordisk has 142 offices.